Tenaya Therapeutics prices public offering of 75 million units at $52.5 million

From GlobeNewswire: 2025-03-03 23:19:31

Tenaya Therapeutics, Inc. announces the pricing of its underwritten public offering of 75,000,000 units, raising approximately $52.5 million. The proceeds will fund development of clinical and early-stage product candidates TN-201 and TN-401. Each unit is priced at $0.70 and includes one share of common stock, a warrant to purchase one share at $0.80, and a warrant to purchase half a share at $0.70. The offering, expected to close on March 5, 2025, is managed by Leerink Partners and Piper Sandler. Securities are offered under a Registration Statement on Form S-3. For more information, visit the SEC’s website or contact Leerink Partners LLC or Piper Sandler & Co.



Read more at GlobeNewswire: Tenaya Therapeutics Announces Pricing of Public Offering